Today's Date
Tezepelumab+Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals with Cat Allergy
(
CATNIP
)
ITN Protocol #:
ITN057AD
Branded Name:
CATNIP
ClinicalTrials.Gov ID:
NCT02237196Treatment Protocol #:
Therapeutic Area:
Allergy & Asthma
Current Status:
Completed
Summary:
Combined Treatment with Allergy Immunotherapy and Tezepelumab in Patients with Allergic Rhinitis
Clinical Operations Associate Director & Manager
ITN Biostat
ITN Clinical Trial Physician
Study Personnel:
